NVIDIA & IQVIA Build Specialized Agentic AI for Life Science & Healthcare Applications
IQVIA, the world's leading provider of clinical research services, commercial insights and healthcare intelligence, is working with NVIDIA to build custom foundation models and agentic AI workflows that can accelerate research, clinical development and access to new treatments. AI applications trained on the organization's vast healthcare-specific information and guided by its deep domain expertise will help the industry boost the efficiency of clinical trials and optimize planning for the launch of therapies and medical devices—ultimately improving patient outcomes.
Operating in over 100 countries, IQVIA has built the largest global healthcare network and is uniquely connected to the ecosystem with the most comprehensive and granular set of information, analytics and technologies in the industry. Announced today at the J.P. Morgan Conference in San Francisco, IQVIA's collection of models, AI agents and reference workflows will be developed with the NVIDIA AI Foundry platform for building custom models, allowing IQVIA's thousands of pharmaceutical, biotech and medical device customers to benefit from NVIDIA's agentic AI capabilities and IQVIA's technologies, life sciences information and expertise.
Operating in over 100 countries, IQVIA has built the largest global healthcare network and is uniquely connected to the ecosystem with the most comprehensive and granular set of information, analytics and technologies in the industry. Announced today at the J.P. Morgan Conference in San Francisco, IQVIA's collection of models, AI agents and reference workflows will be developed with the NVIDIA AI Foundry platform for building custom models, allowing IQVIA's thousands of pharmaceutical, biotech and medical device customers to benefit from NVIDIA's agentic AI capabilities and IQVIA's technologies, life sciences information and expertise.